Aimil Pharmaceuticals(India) Limited - Company Profile

It is a healthcare public limited company based in New Delhi, Delhi, India, established in 1984.

1984 New Delhi, Delhi, India Active

Last Updated: January 05, 2026

About Aimil Pharmaceuticals(India) Limited

Aimil Pharmaceuticals(India) Limited, a active public limited company, was established on 30 November 1984 in New Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U24231DL1984PLC019461. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹14.50 Cr and a paid-up capital of ₹11.55 Cr.

Formerly known as Aimil Pharmaceuticals India Private Limited. It upholds a compliant status. Employing 195 professional, Its leadership includes Ikshit Sharma (Director), Sanchit Sharma (Additional Director), Kanwal Kumar Sharma (Managing Director). Past directors included Varinder Pall Singh, Ikshit Sharma, Subhash Sharma. It holds ₹94.34 Cr open charges and ₹24.00 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 2994/4 Street No 17Ranjeet Nagar, New Delhi, Delhi, 110008.

Company Details

CIN/LLPIN
U24231DL1984PLC019461
Registration Number
019461
Incorporation Date
30 November 1984
Authorized Capital
₹14.50 Cr
Paid-Up Capital
₹11.55 Cr
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 14.50 Cr as on 05-01-2026
Paid Up Capital ₹ 11.55 Cr as on 05-01-2026
Company Age 41 Year, 2 Months
Last Filing with ROC 31 Mar 2023
Open Charges ₹ 94.34 Cr as on 05-01-2026
Satisfied Charges ₹ 24.00 Cr as on 05-01-2026
Revenue Growth **** 7.39% (FY 2023)
Profit Growth **** 41.07% (FY 2023)
Ebitda **** 20.12% (FY 2023)
Net Worth 11.95% (FY 2023)
Total Assets **** 26.49% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Aimil Pharmaceuticals(India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aimil Pharmaceuticals(India) Limited?

Current Directors

Name	Designation	Appointment Date	Status
Ikshit Sharma	Director	21 Nov 2019	Current
Sanchit Sharma	Additional Director	12 Feb 2025	Current
Kanwal Kumar Sharma	Managing Director	30 Nov 1984	Current
Pankaj Marwaha	Director	26 Sep 1988	Current
Satya Prakash Shrivastava	Director	18 Aug 2014	Current
Manjula Sharma	Director	24 Jul 1996	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Nominee Director	19 Apr 2016	Past
Pramod Abcsdd	Additional Director	31 Dec 2020	Past
Pramod Abcsdd	Director	24 May 2019	Past
Pramod Abcsdd	Additional Director	25 Sep 2014	Past
Pramod Abcsdd	Company Secretary	-	Past
Pramod Abcsdd	Cfo	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aimil Pharmaceuticals(India).

Aimil Pharmaceuticals(India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.39% increase. The company also saw a substantial improvement in profitability, with a 41.07% increase in profit. The company's net worth Soared by an impressive increase of 11.95%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

7.39%

*******

Revenue from Operations

*******

7.38%

*******

Total Assets

*******

26.49%

*******

Profit or Loss

*******

41.07%

*******

Net Worth

*******

11.95%

*******

EBITDA

*******

20.12%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aimil Pharmaceuticals(India)?

In 2022, Aimil Pharmaceuticals(India) had a promoter holding of 96.44% and a public holding of 3.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹943,415,726.00

Satisfied Charges

₹240,047,500.00

Charges Breakdown by Lending Institutions

Others : 92.59 Cr
Tata Capital Financial Services Limited : 1.75 Cr

Latest Charge Details

Date	Lender	Amount	Status
08 Sep 2023	Tata Capital Financial Services Limited	₹1.75 Cr	Open
29 Oct 2021	Others	₹13.75 Cr	Open
08 Oct 2021	Others	₹3.48 M	Open
14 Oct 2019	Others	₹8.35 M	Open
04 Jan 2017	Others	₹1.59 M	Open

Explore comprehensive loan charge details -

How Many Employees Work at Aimil Pharmaceuticals(India)?

Aimil Pharmaceuticals(India) has a workforce of 195 employees as of Jan 09, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aimil Pharmaceuticals(India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aimil Pharmaceuticals(India)'s trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aimil Pharmaceuticals(India)

Recent Activity within the Organization

Charges

Progress on A charge registered on 23 Jun 2021 via Charge ID 100458782 with Others was fully satisfied on 22 Apr 2025. was documented.
22 Apr 2025
Charges

Progress on A charge registered on 19 Mar 2018 via Charge ID 100186755 with Others was fully satisfied on 22 Apr 2025. was documented.
22 Apr 2025
Charges

Progress on A charge registered on 28 Feb 2014 via Charge ID 10482863 with Punjab National Bank was fully satisfied on 22 Apr 2025. was documented.
22 Apr 2025
Director Appointment

The activity Sanchit Sharma was appointed as a Additional Director was appointed as a Additional Director on 12 Feb 2025 & has been associated with this company since 11 months 29 days . was completed.
12 Feb 2025
Charges

The activity A charge registered on 08 Mar 2017 via Charge ID 100088052 with Others was fully satisfied on 15 Jan 2025. was completed.
15 Jan 2025
Charges

A charge registered on 30 Jul 2016 via Charge ID 100065493 with Others was fully satisfied on 15 Jan 2025. was recorded as a recent event.
15 Jan 2025

Explore recent activity and updates - View Recent Activity